or Try an Advanced Search...

    Technical Analysis for SNOA - Sonoma Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.79 4.10% 0.11
    SNOA closed up 4.1 percent on Friday, November 1, 2024, on 11 percent of normal volume.
    Earnings due: Nov 11
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SNOA trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 4.10%
    Narrow Range Bar Range Contraction 4.10%
    BB Squeeze Ended Range Expansion 4.10%
    Gapped Down Weakness 4.10%
    Bollinger Band Squeeze Range Contraction -3.79%
    Narrow Range Bar Range Contraction -3.79%
    Fell Below 20 DMA Bearish -3.79%
    Bollinger Band Squeeze Range Contraction -3.79%
    NR7 Range Contraction -3.79%
    NR7-2 Range Contraction -3.79%
    Older End-of-Day Signals for SNOA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    Up 5% 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SNOA Chart by TradingView
    Basic chart:

    Profile

    Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Animal Health

    Is SNOA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
    Oct 22 Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
    Oct 21 Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
    Sep 19 Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
    Sep 19 Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
    Sep 17 Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
    Sep 11 Sonoma and EMC to co-market an expanded eye care product line
    Sep 11 Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
    Aug 28 Sonoma Pharmaceuticals to implement a reverse stock split
    Aug 28 Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
    See more SNOA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.374
    52 Week Low 2.318
    Average Volume 191,660
    200-Day Moving Average 3.86
    50-Day Moving Average 3.24
    20-Day Moving Average 2.90
    10-Day Moving Average 2.88
    Average True Range 0.29
    RSI (14) 43.82
    ADX 21.24
    +DI 21.85
    -DI 19.69
    Chandelier Exit (Long, 3 ATRs) 2.53
    Chandelier Exit (Short, 3 ATRs) 3.39
    Upper Bollinger Bands 3.19
    Lower Bollinger Band 2.62
    Percent B (%b) 0.3
    BandWidth 19.55
    MACD Line -0.14
    MACD Signal Line -0.17
    MACD Histogram 0.0214
    Fundamentals Value
    Market Cap 43.54 Million
    Num Shares 15.6 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -1.89
    Price-to-Sales 0.21
    Price-to-Book 0.44
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.03
    Resistance 3 (R3) 3.02 2.94 2.99
    Resistance 2 (R2) 2.94 2.88 2.94 2.98
    Resistance 1 (R1) 2.86 2.84 2.90 2.87 2.96
    Pivot Point 2.78 2.78 2.80 2.78 2.78
    Support 1 (S1) 2.70 2.72 2.74 2.71 2.62
    Support 2 (S2) 2.62 2.68 2.62 2.60
    Support 3 (S3) 2.54 2.62 2.59
    Support 4 (S4) 2.55